Oleg Shinkazh
Principal investigator, leads CHROMATAN INC.
BiotechFounder
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2015First federal award
$9.2MFederal grants as PI11 awards
3Patents grantedLatest Sep 7, 2021
8Papers199 citations
Federal awards and patents by year
AwardsPatents
11 awards · $9.2M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Mar 20, 2025 | NIH | SBIR Phase II Resubmission - Development and scale-up of Continuous Countercurrent Tangential Chromatography (CCTC) for next generation AAV vector manufacturing (Direct to Phase II) | $695K | CHROMATAN INC |
| Sep 11, 2024 | NIH | SBIR Phase II Resubmission - Development and scale-up of Continuous Countercurrent Tangential Chromatography (CCTC) for next generation AAV vector manufacturing (Direct to Phase II) | $214K | CHROMATAN INC |
| May 6, 2024 | NIH | SBIR Phase II Resubmission - Development and scale-up of Continuous Countercurrent Tangential Chromatography (CCTC) for next generation AAV vector manufacturing (Direct to Phase II) | $1.3M | CHROMATAN INC |
| Sep 18, 2023 | NIH | SBIR Phase II Continuation Application for the development of Integrated continuous and single-use (ICS) bioproduction platform (Phase IIB) | $504K | CHROMATAN INC |
| Aug 11, 2023 | NIH | SBIR Phase II Continuation Application for the development of Integrated continuous and single-use (ICS) bioproduction platform (Phase IIB) | $707K | CHROMATAN INC |
| Apr 1, 2022 | NIH | SBIR Phase II Continuation Application for the development of Integrated continuous and single-use (ICS) bioproduction platform (Phase IIB) | $2.5M | CHROMATAN INC |
| Mar 24, 2022 | NIH | SBIR Phase II Continuation Application for the development of Integrated continuous and single-use (ICS) bioproduction platform (Phase IIB) | $1.3M | CHROMATAN INC |
| Sep 13, 2018 | NIH | SBIR Phase II Commercialization of Integrated Continuous and Single-use Bio-production Capture Platform (ICS) | $256K | CHROMATAN INC |
| Mar 2, 2018 | NIH | SBIR Phase II Commercialization of Integrated Continuous and Single-use Bio-production Capture Platform (ICS) | $540K | CHROMATAN INC |
| Mar 10, 2017 | NIH | SBIR Phase II Commercialization of Integrated Continuous and Single-use Bio-production Capture Platform (ICS) | $941K | CHROMATAN INC |
| Dec 24, 2015 | NIH | SBIR Phase II Commercialization of Integrated Continuous and Single-use Bio-production Capture Platform (ICS) | $222K | CHROMATAN INC |
3 patents as inventor
- US 10324070CHROMATAN INCJun 18, 2019
- US 10859542CHROMATAN INCDec 8, 2020
- US 11110374CHROMATAN INCSep 7, 2021
Matched by the first inventor’s name and the patent’s company.
Peer ranks
Federal funding#84
Awards as PI#106
Patents#63
Companies
- CHROMATAN INCLeads (SEC Form D) · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.